Liraglutide ameliorates nonalcoholic fatty liver disease in...

Diabetes Metabolic Syndrome and Obesity Targets and Therapy 2019 / 07 Vol. Volume 12

Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway

Yang, Pijian, Liang, Yuzhen, Luo, Yunchen, Li, Zhengming, Wen, Yumei, Shen, Jing, Li, Ruwen, Zheng, Hua, Gu, Harvest F, Xia, Ning
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
Volume 12
Journal:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
DOI:
10.2147/DMSO.S206867
Date:
July, 2019
File:
PDF, 2.90 MB
2019
Conversion to is in progress
Conversion to is failed